Avanzarx Pharmaceutical Holdings, LLC

Phoenix Pharmalabs, Inc is a privately held pre-clinical stage drug development company based in Utah. They are committed to providing effective pain therapy options without the risks of addiction and severe side effects. The company's lead candidate, PPL-138, boasts 100 times the potency of morphine for pain relief, with a low risk of abuse and no respiratory depression. With a focus on addressing the opioid crisis, Phoenix Pharmalabs is advancing PPL-138 into Phase I human clinical trials by the end of 2023. Their second drug candidate, PPL-103, shows promise not only in pain treatment but also in addiction therapy, demonstrating low abuse potential and reduced opioid side effects. The company has raised over $23 million from various sources for drug development. Phoenix Pharmalabs aims to capture a significant portion of the $30 billion opioid therapeutics market by offering innovative solutions to pain management. By developing drugs with unique opioid receptor characteristics that mitigate abuse and addiction risks, they seek strategic partnerships to further advance their drug candidates through pre-clinical and clinical trials. Generated from the website content

cGMP Validation LLC, established in 1997, is a full-service validation compliance firm based in Huntersville, NC, specializing in the pharmaceutical, biotechnology, and medical device industries. The company offers a range of services including validation, qualification, commissioning, and compliance documentation for equipment, utilities, processes, and laboratory systems. With a commitment to delivering cost-effective and regulatory sound approaches, cGMP Validation has built a client base across the United States, Puerto Rico, and Canada, and has international experience in various countries including Germany, Italy, and Singapore. The firm emphasizes a proven project management strategy and a team approach, ensuring reliable delivery of services tailored to meet client needs. Generated from the website

Biocytics Inc, a privately held biotechnology company located in Huntersville, North Carolina, specializes in cancer immunotherapy and contract services. The company focuses on researching and developing novel cellular therapies to accelerate personalized medicine and collaborates with industry leaders in translational research and biospecimen banking. With a commitment to advancing cancer care, Biocytics offers a range of services including cGMP manufacturing, clinical trial support, and a comprehensive biobank for both industry and patient needs. Their innovative approach leverages the specificity of autologous immune cells to potentially treat solid tumors, aiming to deliver bespoke regenerative medicine solutions effectively and affordably. Generated from the website